Influenza and the use of oseltamivir in children
Identifieur interne : 000433 ( Main/Exploration ); précédent : 000432; suivant : 000434Influenza and the use of oseltamivir in children
Auteurs : Ergin Çiftçi [Turquie] ; Adem Karbuz [Turquie] ; Tan L Kendirli [Turquie]Source :
- Turkish Archives of Pediatrics/Türk Pediatri Arşivi [ 1306-0015 ] ; 2016.
Abstract
Influenza is an infectious disease which causes significant morbidity and mortality. In the USA, approximately 200 000 hospital admissions and 36 000 deaths occur annualy due to severe influenza infections. Although influenza often causes a simple respiratory infection, it sometimes causes disorders affecting several organs including the lung, heart, brain, liver and muscles or serious life-threatening primary viral or secondary bacterial pneumonia. Currently, oseltamivir is the most important and effective drug for severe influenza infections. Severe influenza infections can be controlled and related deaths may be prevented with initiation of this drug especially within first 2 days. Oseltamivir is usually well tolerated and its most commonly reported side effect is related with the gastrointestinal system. In conclusion, the course of influenza changes in a positive direction and the rates of complications and mortality significantly reduce in patients in whom oseltamivir treatment is initiated as soon as possible.
Url:
DOI: 10.5152/TurkPediatriArs.2016.2359
PubMed: 27489462
PubMed Central: 4959743
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Pmc, to step Corpus: 000079
- to stream Pmc, to step Curation: 000079
- to stream Pmc, to step Checkpoint: 000312
- to stream Ncbi, to step Merge: 000D01
- to stream Ncbi, to step Curation: 000D01
- to stream Ncbi, to step Checkpoint: 000D01
- to stream Main, to step Merge: 000433
- to stream Main, to step Curation: 000433
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Influenza and the use of oseltamivir in children</title><author><name sortKey="Ciftci, Ergin" sort="Ciftci, Ergin" uniqKey="Ciftci E" first="Ergin" last="Çiftçi">Ergin Çiftçi</name><affiliation wicri:level="1"><nlm:aff id="af1-tpa_51_2_63">Department of Pediatrics, Division of Pediatric Infectious Diseases, Ankara University School of Medicine, Ankara, Turkey</nlm:aff><country xml:lang="fr">Turquie</country><wicri:regionArea>Department of Pediatrics, Division of Pediatric Infectious Diseases, Ankara University School of Medicine, Ankara</wicri:regionArea><wicri:noRegion>Ankara</wicri:noRegion></affiliation></author><author><name sortKey="Karbuz, Adem" sort="Karbuz, Adem" uniqKey="Karbuz A" first="Adem" last="Karbuz">Adem Karbuz</name><affiliation wicri:level="1"><nlm:aff id="af1-tpa_51_2_63">Department of Pediatrics, Division of Pediatric Infectious Diseases, Ankara University School of Medicine, Ankara, Turkey</nlm:aff><country xml:lang="fr">Turquie</country><wicri:regionArea>Department of Pediatrics, Division of Pediatric Infectious Diseases, Ankara University School of Medicine, Ankara</wicri:regionArea><wicri:noRegion>Ankara</wicri:noRegion></affiliation></author><author><name sortKey="Kendirli, Tan L" sort="Kendirli, Tan L" uniqKey="Kendirli T" first="Tan L" last="Kendirli">Tan L Kendirli</name><affiliation wicri:level="1"><nlm:aff id="af2-tpa_51_2_63">Division of Pediatric Intensive Care, Department of Pediatrics, Ankara University School of Medicine, Ankara, Turkey</nlm:aff><country xml:lang="fr">Turquie</country><wicri:regionArea>Division of Pediatric Intensive Care, Department of Pediatrics, Ankara University School of Medicine, Ankara</wicri:regionArea><wicri:noRegion>Ankara</wicri:noRegion></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PMC</idno><idno type="pmid">27489462</idno><idno type="pmc">4959743</idno><idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4959743</idno><idno type="RBID">PMC:4959743</idno><idno type="doi">10.5152/TurkPediatriArs.2016.2359</idno><date when="2016">2016</date><idno type="wicri:Area/Pmc/Corpus">000079</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">000079</idno><idno type="wicri:Area/Pmc/Curation">000079</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">000079</idno><idno type="wicri:Area/Pmc/Checkpoint">000312</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Checkpoint">000312</idno><idno type="wicri:Area/Ncbi/Merge">000D01</idno><idno type="wicri:Area/Ncbi/Curation">000D01</idno><idno type="wicri:Area/Ncbi/Checkpoint">000D01</idno><idno type="wicri:doubleKey">1306-0015:2016:Ciftci E:influenza:and:the</idno><idno type="wicri:Area/Main/Merge">000433</idno><idno type="wicri:Area/Main/Curation">000433</idno><idno type="wicri:Area/Main/Exploration">000433</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">Influenza and the use of oseltamivir in children</title><author><name sortKey="Ciftci, Ergin" sort="Ciftci, Ergin" uniqKey="Ciftci E" first="Ergin" last="Çiftçi">Ergin Çiftçi</name><affiliation wicri:level="1"><nlm:aff id="af1-tpa_51_2_63">Department of Pediatrics, Division of Pediatric Infectious Diseases, Ankara University School of Medicine, Ankara, Turkey</nlm:aff><country xml:lang="fr">Turquie</country><wicri:regionArea>Department of Pediatrics, Division of Pediatric Infectious Diseases, Ankara University School of Medicine, Ankara</wicri:regionArea><wicri:noRegion>Ankara</wicri:noRegion></affiliation></author><author><name sortKey="Karbuz, Adem" sort="Karbuz, Adem" uniqKey="Karbuz A" first="Adem" last="Karbuz">Adem Karbuz</name><affiliation wicri:level="1"><nlm:aff id="af1-tpa_51_2_63">Department of Pediatrics, Division of Pediatric Infectious Diseases, Ankara University School of Medicine, Ankara, Turkey</nlm:aff><country xml:lang="fr">Turquie</country><wicri:regionArea>Department of Pediatrics, Division of Pediatric Infectious Diseases, Ankara University School of Medicine, Ankara</wicri:regionArea><wicri:noRegion>Ankara</wicri:noRegion></affiliation></author><author><name sortKey="Kendirli, Tan L" sort="Kendirli, Tan L" uniqKey="Kendirli T" first="Tan L" last="Kendirli">Tan L Kendirli</name><affiliation wicri:level="1"><nlm:aff id="af2-tpa_51_2_63">Division of Pediatric Intensive Care, Department of Pediatrics, Ankara University School of Medicine, Ankara, Turkey</nlm:aff><country xml:lang="fr">Turquie</country><wicri:regionArea>Division of Pediatric Intensive Care, Department of Pediatrics, Ankara University School of Medicine, Ankara</wicri:regionArea><wicri:noRegion>Ankara</wicri:noRegion></affiliation></author></analytic><series><title level="j">Turkish Archives of Pediatrics/Türk Pediatri Arşivi</title><idno type="ISSN">1306-0015</idno><idno type="eISSN">1308-6278</idno><imprint><date when="2016">2016</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><p>Influenza is an infectious disease which causes significant morbidity and mortality. In the USA, approximately 200 000 hospital admissions and 36 000 deaths occur annualy due to severe influenza infections. Although influenza often causes a simple respiratory infection, it sometimes causes disorders affecting several organs including the lung, heart, brain, liver and muscles or serious life-threatening primary viral or secondary bacterial pneumonia. Currently, oseltamivir is the most important and effective drug for severe influenza infections. Severe influenza infections can be controlled and related deaths may be prevented with initiation of this drug especially within first 2 days. Oseltamivir is usually well tolerated and its most commonly reported side effect is related with the gastrointestinal system. In conclusion, the course of influenza changes in a positive direction and the rates of complications and mortality significantly reduce in patients in whom oseltamivir treatment is initiated as soon as possible.</p></div></front></TEI><affiliations><list><country><li>Turquie</li></country></list><tree><country name="Turquie"><noRegion><name sortKey="Ciftci, Ergin" sort="Ciftci, Ergin" uniqKey="Ciftci E" first="Ergin" last="Çiftçi">Ergin Çiftçi</name></noRegion><name sortKey="Karbuz, Adem" sort="Karbuz, Adem" uniqKey="Karbuz A" first="Adem" last="Karbuz">Adem Karbuz</name><name sortKey="Kendirli, Tan L" sort="Kendirli, Tan L" uniqKey="Kendirli T" first="Tan L" last="Kendirli">Tan L Kendirli</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/H2N2V1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000433 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000433 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= H2N2V1
|flux= Main
|étape= Exploration
|type= RBID
|clé= PMC:4959743
|texte= Influenza and the use of oseltamivir in children
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:27489462" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a H2N2V1
| This area was generated with Dilib version V0.6.33. |  |